Sponsor Spotlight: genedrive Advancing Safer, More Personalised Care Through Rapid Pharmacogenetic Testing
Posted:
We are pleased to welcome genedrive as a sponsor and exhibitor at this year’s GIANT Health Event.
Based in Manchester, genedrive is a diagnostics company developing rapid pharmacogenetic testing solutions designed to support safer, more effective prescribing decisions. By helping clinicians understand how a patient’s genetic profile may influence their response to specific medicines, genedrive’s technology supports the move towards more personalised and precision healthcare.
The company’s rapid testing platforms are already being used in clinical practice across important care pathways, supporting healthcare professionals in making informed treatment decisions where time and accuracy are critical.
Current applications include:
-
Supporting stroke care pathways: genedrive technology is being used in hyperacute stroke units, including the UK’s largest stroke unit at Salford Hyper Acute Stroke Unit, to help guide antiplatelet therapy decisions and support personalised treatment.
-
Improving neonatal care: genedrive’s MT-RNR1 testing is being implemented across 14 neonatal intensive care units in England and Wales through the NHS PALOH-UK programme, helping identify babies at risk of hearing loss from certain antibiotic treatments.
-
Expanding adoption internationally: the technology continues to gain recognition through regional and international implementation, including a national rollout of Genedrive® MT-RNR1 testing across neonatal units in Scotland and adoption at Erasmus University Medical Center in Rotterdam.